ArticlePloS one2026
Differences by sex and type of hypertension in mortality from hypertensive diseases between 1997 and 2020, and predictions for 2035 in Latin American and Caribbean countries.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertension is the most prevalent cardiovascular condition and a leading contributor to premature mortality in Latin America and the Caribbean (LAC). Despite its public health relevance, few studies have examined long-term trends in hypertensive disease mortality across the region. The objective was to analyze trends in mortality due to hypertensive diseases from 1997 to 2020 in LAC countries, disaggregated by sex and type of hypertension, and to project mortality rates to 2035.
methodsWe conducted an ecological time-series study using age-standardized mortality rates (ASMRs) extracted from the World Health Organization Mortality Database. Mortality from hypertensive diseases was defined by ICD-10 codes I10-I13 and further stratified into primary hypertension (I10) and hypertension-mediated organ damage (HMOD, I11-I13). Trends were assessed using Joinpoint regression to estimate average annual percent change (AAPC) and 95% confidence intervals (95%CI). Projections to 2035 were calculated using Norpred based on age - period - cohort analysis.
resultsBetween 1997 and 2020, mortality from hypertensive diseases increased in most LAC countries. Among men, significant increases were observed in Brazil (AAPC: 2.6%), El Salvador (6.6%), and Panama (6.1%), while Trinidad and Tobago was the only country showing a significant decline (AAPC: -5.7%). Among women, the most marked increase was seen in El Salvador (7.6%). By 2035, the Dominican Republic, Venezuela, and Paraguay are projected to have the highest ASMRs for hypertensive diseases among men, while for women, the Dominican Republic and Venezuela will remain among the most affected. Mortality from primary hypertension represented the greatest burden across countries, while HMOD exhibited lower but variable rates.
conclusionHypertensive disease mortality is projected to rise in LAC, with notable disparities by sex, country, and type of hypertension. These findings underscore the urgent need for regionally tailored prevention, screening, and control strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.